HER-2 POSITIVE BREAST CANCER
Clinical trials for HER-2 POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER-2 POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for HER-2 POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Smart combo therapy aims to boost remission in HER2+ breast cancer
Disease control Not yet recruitingThis study tests a new combination of drugs (PLD, cyclophosphamide, trastuzumab, and pertuzumab) for people with HER2-positive early breast cancer who still have cancer after initial treatment. The goal is to see if this combo can increase the rate of complete remission before su…
Matched conditions: HER-2 POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 08, 2026 13:03 UTC
-
New MRI dye could spot brain tumors sooner in cancer patients
Diagnosis Not yet recruitingThis study tests whether a new MRI contrast agent, gadopiclenol, can detect brain metastases earlier than standard methods in 180 patients with advanced lung, breast, or skin cancer. Participants will receive screening brain MRIs to compare diagnosis timing and accuracy. The goal…
Matched conditions: HER-2 POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: University of Zurich • Aim: Diagnosis
Last updated Jun 22, 2026 12:07 UTC
-
Can a potato starch supplement ease cancer drug side effects?
Knowledge-focused Not yet recruitingThis study will track gut microbiome changes in 12 women with hormone receptor-positive breast cancer starting Verzenio (abemaciclib) therapy. Participants will take either a resistant potato starch supplement or a placebo, and provide stool samples and symptom questionnaires rem…
Matched conditions: HER-2 POSITIVE BREAST CANCER
Phase: NA • Sponsor: University of Vermont Medical Center • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:55 UTC